[Varicella-zoster meningoencephalitis and vasculitis after treatment with amenamevir to herpes zoster in the trigeminal nerve area]

Rinsho Shinkeigaku. 2021 Apr 21;61(4):239-242. doi: 10.5692/clinicalneurol.cn-001531. Epub 2021 Mar 25.
[Article in Japanese]

Abstract

A 78-year-old woman was diagnosed with herpes zoster in the first branch of the trigeminal nerve and was treated with amenamevir. Subsequently, she was hospitalized for postherpetic neuralgia. Fever and unconsciousness were observed, and a diagnosis of varicella-zoster virus meningoencephalitis and vasculitis was made. In addition to the antithrombotic therapy, she was treated with intravenous acyclovir and steroid pulse therapy; however, her unconsciousness persisted. Amenamevir was not transferrable to the spinal fluid and resulted in an incomplete treatment of herpes zoster in the cerebral nerve region, suggesting that this case may be related to the severe course of the disease.

Keywords: amenamevir; varicella-zoster virus meningoencephalitis; varicella-zoster virus vasculitis.

Publication types

  • Case Reports

MeSH terms

  • Acyclovir / administration & dosage*
  • Aged
  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Antiviral Agents / cerebrospinal fluid
  • Antiviral Agents / therapeutic use*
  • Female
  • Herpes Zoster / complications*
  • Herpes Zoster / drug therapy*
  • Humans
  • Infusions, Intravenous
  • Magnetic Resonance Imaging
  • Meningoencephalitis / diagnosis
  • Meningoencephalitis / drug therapy*
  • Meningoencephalitis / etiology*
  • Meningoencephalitis / virology
  • Methylprednisolone / administration & dosage
  • Oxadiazoles / adverse effects
  • Oxadiazoles / cerebrospinal fluid
  • Oxadiazoles / therapeutic use*
  • Pulse Therapy, Drug
  • Severity of Illness Index
  • Trigeminal Nerve*
  • Vasculitis / diagnosis
  • Vasculitis / drug therapy*
  • Vasculitis / etiology*
  • Vasculitis / virology

Substances

  • ASP2151
  • Antiviral Agents
  • Oxadiazoles
  • Acyclovir
  • Methylprednisolone